Integrin α1/Akita double-knockout mice on a Balb/c background develop advanced features of human diabetic nephropathy

Ling Yu1, Yan Su, Paisit Paueksakon

  • 1Division of Nephrology, Department of Medicine, Vanderbilt University, Nashville, Tennessee 37232, USA.

Kidney International
|February 3, 2012
PubMed

Insights

A new mouse model combining Akita and integrin alpha1 knockout mutations on a Balb/c background effectively mimics human diabetic nephropathy, showing severe kidney damage and impaired filtration.

Area of Science:

  • Nephrology
  • Diabetology
  • Genetics

Background:

  • Diabetic nephropathy (DN) is a major complication of diabetes.
  • Existing mouse models do not fully replicate human DN pathology.
  • The Akita mouse model exhibits type 1 diabetes due to an insulin-2 gene mutation.

Purpose of the Study:

  • To develop a novel mouse model that better mimics human diabetic nephropathy.
  • To investigate the combined effects of Akita mutation and integrin alpha1 knockout on kidney disease.

Main Methods:

  • Generation of Akita knockout (KO) mice on a Balb/c background.
  • Crossbreeding Akita KO mice with integrin alpha1 knockout (α1KO) mice.
  • Assessment of kidney pathology, albuminuria, and glomerular filtration rate.

Main Results:

  • Akita KO mice on Balb/c background developed hyperglycemia and albuminuria.
  • Double KO (α1KOAkitaKO) mice exhibited a 16-fold increase in albuminuria.
  • α1KOAkitaKO mice showed significant glomerulosclerosis, mesangial expansion, and reduced glomerular filtration.

Conclusions:

  • The integrin α1KOAkitaKO Balb/c mouse model demonstrates key pathological and functional features of human diabetic nephropathy.
  • This model offers a valuable tool for studying DN pathogenesis and testing new therapies.